Cargando…

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya

BACKGROUND: In 2009, Gavi, the World Bank, and donors launched the pneumococcal Advance Market Commitment, which helped countries access more affordable pneumococcal vaccines. As many low-income countries begin to reach the threshold at which countries transition from Gavi support to self-financing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ojal, John, Griffiths, Ulla, Hammitt, Laura L, Adetifa, Ifedayo, Akech, Donald, Tabu, Collins, Scott, J Anthony G, Flasche, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484775/ https://www.ncbi.nlm.nih.gov/pubmed/31000132 http://dx.doi.org/10.1016/S2214-109X(18)30562-X

Ejemplares similares

Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data
por: Ojal, John, et al.
Publicado: (2017)

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
por: Hammitt, Laura L, et al.
Publicado: (2019)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023)

Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects
por: Botwright, Siobhan, et al.
Publicado: (2017)

The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria
por: Adamu, Aishatu Lawal, et al.
Publicado: (2022)

Challenges to sustainable immunization systems in Gavi transitioning countries
por: Cernuschi, Tania, et al.
Publicado: (2018)

The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya
por: Mburu, C. N., et al.
Publicado: (2021)

Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya
por: Adetifa, Ifedayo M.O., et al.
Publicado: (2018)

Estimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study
por: Flasche, Stefan, et al.
Publicado: (2020)

Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
por: Orangi, Stacey, et al.
Publicado: (2022)

Vaccine strategies to reduce the burden of pneumococcal disease in HIV-infected adults in Africa.
por: Thindwa, Deus, et al.
Publicado: (2020)

Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage
por: Ojal, John, et al.
Publicado: (2017)

Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?
por: Griffiths, Ulla Kou, et al.
Publicado: (2016)

Inequities in childhood immunisation coverage associated with socioeconomic, geographic, maternal, child, and place of birth characteristics in Kenya
por: Allan, Simon, et al.
Publicado: (2021)

Gavi HPV Programs: Application to Implementation
por: Hanson, Celina M., et al.
Publicado: (2015)

Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya
por: Flasche, Stefan, et al.
Publicado: (2017)

Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries
por: Saxenian, Helen, et al.
Publicado: (2015)

Resource Allocation Strategies to Increase the Efficiency and Sustainability of Gavi’s Health System Strengthening Grants
por: Mimche, Honoré, et al.
Publicado: (2018)

Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies
por: Hammitt, Laura L, et al.
Publicado: (2014)

Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi
por: Thindwa, Deus, et al.
Publicado: (2022)

Examining the unit costs of COVID-19 vaccine delivery in Kenya
por: Orangi, Stacey, et al.
Publicado: (2022)

Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction
por: Soble, Adam, et al.
Publicado: (2020)

Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support
por: Ferrinho, Paulo, et al.
Publicado: (2013)

Evaluating Country Performance After Transitioning From Gavi Assistance: An Applied Synthetic Control Analysis
por: Kolesar, Robert John, et al.
Publicado: (2023)

Post-GAVI sustainability of the Haemophilus influenzae type b vaccine program: The potential role of economic evaluation
por: Le, Phuc, et al.
Publicado: (2016)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

The GAVI Alliance and the ‘Gates approach’ to health system strengthening
por: Storeng, Katerini T.
Publicado: (2014)

Assessment of select electronic health information systems that support immunization data capture – Kenya, 2017
por: Namageyo-Funa, Apophia, et al.
Publicado: (2018)

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries
por: Marijam, Alen, et al.
Publicado: (2022)

Health and economic impact of rotavirus vaccination in GAVI-eligible countries
por: Kim, Sun-Young, et al.
Publicado: (2010)

GAVI supply chain strategy people and practice evidence review
por: Steele, Pamela
Publicado: (2014)

The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models
por: Baral, Ranju, et al.
Publicado: (2020)

Pre-Vaccination Nasopharyngeal Pneumococcal Carriage in a Nigerian Population: Epidemiology and Population Biology
por: Adetifa, Ifedayo M. O., et al.
Publicado: (2012)

Rates of Acquisition of Pneumococcal Colonization and Transmission Probabilities, by Serotype, Among Newborn Infants in Kilifi District, Kenya
por: Tigoi, Caroline C., et al.
Publicado: (2012)

Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2019)

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis
por: Chen, Cynthia, et al.
Publicado: (2018)

Advancing Immunization Coverage and Equity: A Structured Synthesis of Pro-Equity Strategies in 61 Gavi-Supported Countries
por: Ivanova, Vesela, et al.
Publicado: (2023)

Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward
por: Russell, Allyson L, et al.
Publicado: (2023)

Cohort Profile: The Kilifi Vaccine Monitoring Study
por: Adetifa, Ifedayo MO, et al.
Publicado: (2017)

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
por: Bilcke, Joke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9ipoii518rj0oj3qjkv248t5nr